Rocket One (RKTO) Cash & Equivalents (2017 - 2026)
Rocket One's (RKTO) quarterly Cash & Equivalents came in at $7.9 million in Q2 2026, down 12.45% year-over-year from $9.0 million in Q2 2025, and up 95.0% quarter-over-quarter from $4.0 million in Q1 2026.
Analysis
Rocket One (RKTO) Cash & Equivalents (2017 - 2026) Analysis & Trends
Rocket One has disclosed Cash & Equivalents across 10 years of filings, most recently posting $7.9 million for Q2 2026.
- In Q2 2026, Cash & Equivalents fell 12.45% year-over-year to $7.9 million; the TTM figure through Jun 2026 stood at $7.9 million (down 12.45% YoY), while the FY2025 annual figure was $6.2 million, down 11.24% from the prior year.
- Cash & Equivalents came in at $7.9 million for Q2 2026 at Rocket One, up from $4.0 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $13.0 million in Q1 2023 to a low of $4.0 million in Q1 2026.
- Average Cash & Equivalents over 5 years is $8.7 million, with a median of $8.5 million recorded in 2022.
- Year-over-year, Cash & Equivalents sank 66.94% in 2022 and soared 104.43% in 2023.
- Over 5 years, Cash & Equivalents stood at $6.4 million in 2022, then surged by 44.55% to $9.3 million in 2023, then declined by 24.25% to $7.0 million in 2024, then declined by 11.24% to $6.2 million in 2025, then climbed by 26.32% to $7.9 million in 2026.
- Per Business Quant data, the three most recent Cash & Equivalents figures were $7.9 million in Q2 2026, $4.0 million in Q1 2026, and $6.2 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 13.99 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 3.18 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 6.14 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 2.46 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 3.58 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 1.72 Bn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 1.71 Bn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 1.29 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 1.25 Bn |
| 10 | Rocket One | 13.86 Mn | 5.97 Mn | - | 7.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.89 Mn |
| Mar 31, 2026 | 4.05 Mn |
| Dec 31, 2025 | 6.25 Mn |
| Sep 30, 2025 | 7.85 Mn |
| Jun 30, 2025 | 9.01 Mn |
| Mar 31, 2025 | 11.32 Mn |
| Dec 31, 2024 | 7.04 Mn |
| Sep 30, 2024 | 8.02 Mn |
| Jun 30, 2024 | 9.65 Mn |
| Mar 31, 2024 | 7.60 Mn |
| Dec 31, 2023 | 9.29 Mn |
| Sep 30, 2023 | 11.83 Mn |
| Jun 30, 2023 | 11.54 Mn |
| Mar 31, 2023 | 13.04 Mn |
| Dec 31, 2022 | 6.43 Mn |
| Sep 30, 2022 | 8.94 Mn |
| Jun 30, 2022 | 11.32 Mn |
| Mar 31, 2022 | 6.38 Mn |
| Dec 31, 2021 | 8.54 Mn |
| Sep 30, 2021 | 12.45 Mn |